Loss of TNF-α-regulated COX-2 expression in ovarian cancer cells

Wan Lin Yang, Isabelle H. Roland, Andrew K. Godwin, Xiangxi Xu

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Cyclooxygenase 2 (COX-2) is often found overexpressed in cancer and is thought to have a role in carcinogenic promotion, and thus is a target for therapeutic intervention. Here, we investigated the regulation of COX-2 expression in normal and cancer ovarian surface epithelial cells. Tumor necrosis factor alpha (TNF-α) is a potent inducer of COX-2 expression in the ovarian surface epithelium and this regulation is a critical step in ovulation. We observed that TNF-α stimulated COX-2 expression in human primary and immortalized epithelial (HIO) cell lines. The stimulation was suppressed by inhibitors of several signaling pathways, indicating the collaboration of TNF-α-activated signaling pathways mediates the regulation of COX-2 expression. In five ovarian cancer cell lines analysed, four did not express detectable COX-2 and TNF-α failed to elicit COX-2 expression. In NIH:OVCAR-5, the only ovarian cancer cell line expressing COX-2, signal pathway inhibitors no longer affected TNF-α-induced COX-2 expression. Thus, we conclude that TNF-α mediated signaling is uncoupled from the modulation of COX-2 expression in ovarian cancer. The loss of COX-2 expression was also observed to associate closely with epithelial neoplastic morphological transformation. The frequent loss of COX-2 expression suggests in ovarian cancer, unlike in other epithelial cancers, COX-2 expression does not contribute to ovarian cancer malignancy.

Original languageEnglish
Pages (from-to)7991-8002
Number of pages12
JournalOncogene
Volume24
Issue number54
DOIs
StatePublished - Dec 1 2005
Externally publishedYes

Fingerprint

Cyclooxygenase 2
Ovarian Neoplasms
Tumor Necrosis Factor-alpha
Cell Line
Epithelial Cells
Neoplasms
Ovulation
Signal Transduction
Epithelium

Keywords

  • Cyclooxygenases
  • Ovarian carcinomas
  • Ovarian epithelial cells
  • TNF-α

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Loss of TNF-α-regulated COX-2 expression in ovarian cancer cells. / Yang, Wan Lin; Roland, Isabelle H.; Godwin, Andrew K.; Xu, Xiangxi.

In: Oncogene, Vol. 24, No. 54, 01.12.2005, p. 7991-8002.

Research output: Contribution to journalArticle

Yang, Wan Lin ; Roland, Isabelle H. ; Godwin, Andrew K. ; Xu, Xiangxi. / Loss of TNF-α-regulated COX-2 expression in ovarian cancer cells. In: Oncogene. 2005 ; Vol. 24, No. 54. pp. 7991-8002.
@article{1a007150b99640b79085a2bdacae43af,
title = "Loss of TNF-α-regulated COX-2 expression in ovarian cancer cells",
abstract = "Cyclooxygenase 2 (COX-2) is often found overexpressed in cancer and is thought to have a role in carcinogenic promotion, and thus is a target for therapeutic intervention. Here, we investigated the regulation of COX-2 expression in normal and cancer ovarian surface epithelial cells. Tumor necrosis factor alpha (TNF-α) is a potent inducer of COX-2 expression in the ovarian surface epithelium and this regulation is a critical step in ovulation. We observed that TNF-α stimulated COX-2 expression in human primary and immortalized epithelial (HIO) cell lines. The stimulation was suppressed by inhibitors of several signaling pathways, indicating the collaboration of TNF-α-activated signaling pathways mediates the regulation of COX-2 expression. In five ovarian cancer cell lines analysed, four did not express detectable COX-2 and TNF-α failed to elicit COX-2 expression. In NIH:OVCAR-5, the only ovarian cancer cell line expressing COX-2, signal pathway inhibitors no longer affected TNF-α-induced COX-2 expression. Thus, we conclude that TNF-α mediated signaling is uncoupled from the modulation of COX-2 expression in ovarian cancer. The loss of COX-2 expression was also observed to associate closely with epithelial neoplastic morphological transformation. The frequent loss of COX-2 expression suggests in ovarian cancer, unlike in other epithelial cancers, COX-2 expression does not contribute to ovarian cancer malignancy.",
keywords = "Cyclooxygenases, Ovarian carcinomas, Ovarian epithelial cells, TNF-α",
author = "Yang, {Wan Lin} and Roland, {Isabelle H.} and Godwin, {Andrew K.} and Xiangxi Xu",
year = "2005",
month = "12",
day = "1",
doi = "10.1038/sj.onc.1208943",
language = "English",
volume = "24",
pages = "7991--8002",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "54",

}

TY - JOUR

T1 - Loss of TNF-α-regulated COX-2 expression in ovarian cancer cells

AU - Yang, Wan Lin

AU - Roland, Isabelle H.

AU - Godwin, Andrew K.

AU - Xu, Xiangxi

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Cyclooxygenase 2 (COX-2) is often found overexpressed in cancer and is thought to have a role in carcinogenic promotion, and thus is a target for therapeutic intervention. Here, we investigated the regulation of COX-2 expression in normal and cancer ovarian surface epithelial cells. Tumor necrosis factor alpha (TNF-α) is a potent inducer of COX-2 expression in the ovarian surface epithelium and this regulation is a critical step in ovulation. We observed that TNF-α stimulated COX-2 expression in human primary and immortalized epithelial (HIO) cell lines. The stimulation was suppressed by inhibitors of several signaling pathways, indicating the collaboration of TNF-α-activated signaling pathways mediates the regulation of COX-2 expression. In five ovarian cancer cell lines analysed, four did not express detectable COX-2 and TNF-α failed to elicit COX-2 expression. In NIH:OVCAR-5, the only ovarian cancer cell line expressing COX-2, signal pathway inhibitors no longer affected TNF-α-induced COX-2 expression. Thus, we conclude that TNF-α mediated signaling is uncoupled from the modulation of COX-2 expression in ovarian cancer. The loss of COX-2 expression was also observed to associate closely with epithelial neoplastic morphological transformation. The frequent loss of COX-2 expression suggests in ovarian cancer, unlike in other epithelial cancers, COX-2 expression does not contribute to ovarian cancer malignancy.

AB - Cyclooxygenase 2 (COX-2) is often found overexpressed in cancer and is thought to have a role in carcinogenic promotion, and thus is a target for therapeutic intervention. Here, we investigated the regulation of COX-2 expression in normal and cancer ovarian surface epithelial cells. Tumor necrosis factor alpha (TNF-α) is a potent inducer of COX-2 expression in the ovarian surface epithelium and this regulation is a critical step in ovulation. We observed that TNF-α stimulated COX-2 expression in human primary and immortalized epithelial (HIO) cell lines. The stimulation was suppressed by inhibitors of several signaling pathways, indicating the collaboration of TNF-α-activated signaling pathways mediates the regulation of COX-2 expression. In five ovarian cancer cell lines analysed, four did not express detectable COX-2 and TNF-α failed to elicit COX-2 expression. In NIH:OVCAR-5, the only ovarian cancer cell line expressing COX-2, signal pathway inhibitors no longer affected TNF-α-induced COX-2 expression. Thus, we conclude that TNF-α mediated signaling is uncoupled from the modulation of COX-2 expression in ovarian cancer. The loss of COX-2 expression was also observed to associate closely with epithelial neoplastic morphological transformation. The frequent loss of COX-2 expression suggests in ovarian cancer, unlike in other epithelial cancers, COX-2 expression does not contribute to ovarian cancer malignancy.

KW - Cyclooxygenases

KW - Ovarian carcinomas

KW - Ovarian epithelial cells

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=28544440746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28544440746&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208943

DO - 10.1038/sj.onc.1208943

M3 - Article

C2 - 16044148

AN - SCOPUS:28544440746

VL - 24

SP - 7991

EP - 8002

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 54

ER -